Lv3
392 积分 2023-11-06 加入
Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survival
22天前
已完结
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial
23天前
已完结
Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with90Y Glass Microspheres
23天前
已完结
Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survival
23天前
已完结
Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular Carcinoma
23天前
已完结
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
23天前
已完结
Advances in Locoregional and Systemic Treatments for Hepatocellular Carcinoma
23天前
已完结
Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures
23天前
已完结
BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update
23天前
已完结
皖公网安备34019202002308
